Wells Fargo’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.7K | Sell |
2,329
-33,122
| -93% | -$38.4K | ﹤0.01% | 5713 |
|
|
2025
Q1 | $47.9K | Sell |
35,451
-50,429
| -59% | -$68.1K | ﹤0.01% | 4970 |
|
|
2024
Q4 | $1.13M | Sell |
85,880
-7,352
| -8% | -$96.8K | ﹤0.01% | 3190 |
|
|
2024
Q3 | $1.05M | Buy |
93,232
+13,006
| +16% | +$146K | ﹤0.01% | 3184 |
|
|
2024
Q2 | $862K | Buy |
80,226
+8,876
| +12% | +$95.4K | ﹤0.01% | 3258 |
|
|
2024
Q1 | $1.06M | Buy |
71,350
+2,180
| +3% | +$32.5K | ﹤0.01% | 3101 |
|
|
2023
Q4 | $1.25M | Buy |
69,170
+51,468
| +291% | +$932K | ﹤0.01% | 2963 |
|
|
2023
Q3 | $307K | Sell |
17,702
-6,934
| -28% | -$120K | ﹤0.01% | 3792 |
|
|
2023
Q2 | $446K | Buy |
24,636
+23,294
| +1,736% | +$422K | ﹤0.01% | 3821 |
|
|
2023
Q1 | $35.7K | Buy |
1,342
+1,113
| +486% | +$29.6K | ﹤0.01% | 5050 |
|
|
2022
Q4 | $4.43K | Sell |
229
-204
| -47% | -$3.94K | ﹤0.01% | 5485 |
|
|
2022
Q3 | $9K | Buy |
433
+75
| +21% | +$1.56K | ﹤0.01% | 5402 |
|
|
2022
Q2 | $3K | Sell |
358
-1,857
| -84% | -$15.6K | ﹤0.01% | 5910 |
|
|
2022
Q1 | $15K | Sell |
2,215
-8,503
| -79% | -$57.6K | ﹤0.01% | 5780 |
|
|
2021
Q4 | $145K | Buy |
10,718
+10,508
| +5,004% | +$142K | ﹤0.01% | 5063 |
|
|
2021
Q3 | $4K | Sell |
210
-41,536
| -99% | -$791K | ﹤0.01% | 6116 |
|
|
2021
Q2 | $1.22M | Buy |
41,746
+10,694
| +34% | +$312K | ﹤0.01% | 3864 |
|
|
2021
Q1 | $1.22M | Buy |
31,052
+15,350
| +98% | +$604K | ﹤0.01% | 3856 |
|
|
2020
Q4 | $357K | Buy |
15,702
+7,660
| +95% | +$174K | ﹤0.01% | 4664 |
|
|
2020
Q3 | $182K | Buy |
+8,042
| New | +$182K | ﹤0.01% | 4836 |
|